239 related articles for article (PubMed ID: 37421509)
1. Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.
Abd-Elsalam WH; Abouelatta SM
AAPS PharmSciTech; 2023 Jul; 24(6):150. PubMed ID: 37421509
[TBL] [Abstract][Full Text] [Related]
2. Novel Drug Delivery Strategies for the Treatment of Onychomycosis.
Dhamoon RK; Popli H; Gupta M
Pharm Nanotechnol; 2019; 7(1):24-38. PubMed ID: 31092174
[TBL] [Abstract][Full Text] [Related]
3. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
4. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
5. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
6. Insights into drug delivery across the nail plate barrier.
Saner MV; Kulkarni AD; Pardeshi CV
J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
[TBL] [Abstract][Full Text] [Related]
7. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery to the nail: therapeutic options and challenges for onychomycosis.
Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
Crit Rev Ther Drug Carrier Syst; 2014; 31(6):459-94. PubMed ID: 25271773
[TBL] [Abstract][Full Text] [Related]
9. Routes of drug delivery into the nail apparatus: Implications for the efficacy of topical nail solutions in onychomycosis.
Gupta AK; Simpson FC
J Dermatolog Treat; 2016; 27(1):2-4. PubMed ID: 25983025
[TBL] [Abstract][Full Text] [Related]
10. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis.
Gupta AK; Polla Ravi S; Choi SY; Konda A; Cooper EA
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):243-255. PubMed ID: 36196052
[TBL] [Abstract][Full Text] [Related]
11. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
12. Chemical and physical strategies in onychomycosis topical treatment: A review.
Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
[TBL] [Abstract][Full Text] [Related]
13. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
Brown M; Turner R; Wevrett SR
Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
[TBL] [Abstract][Full Text] [Related]
14. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
15. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
16. Emergence of nail lacquers as potential transungual delivery system in the management of onchomycosis.
Kataria P; Sharma G; Thakur K; Bansal V; Dogra S; Katare OP
Expert Opin Drug Deliv; 2016 Jul; 13(7):937-52. PubMed ID: 27054394
[TBL] [Abstract][Full Text] [Related]
17. Treatment and management strategies of onychomycosis.
Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
[TBL] [Abstract][Full Text] [Related]
18. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
[TBL] [Abstract][Full Text] [Related]
19. Potential of Naftifine Application for Transungual Delivery.
Šveikauskaitė I; Briedis V
Molecules; 2020 Jul; 25(13):. PubMed ID: 32635240
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.
Vikas A; Rashmin P; Mrunali P; Chavan RB; Kaushik T
AAPS PharmSciTech; 2020 Jan; 21(2):67. PubMed ID: 31938980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]